Will there be a shortage this summer?


  • Paracetamol is the most consumed pain reliever in France, according to Vidal.
  • It can be purchased at pharmacies without a prescription.

To date there are delays in the supply of oral forms and ovules of paracetamolensures the National Agency for the Safety of Medicines and Health Products (ANSM). Based on the data available at this time, the situation should return to normal by the end of the summer period.”.

There are two main reasons for this situation: supply difficulties and the increase in paracetamol consumption in the context of the seventh wave of Covid-19.

Effective for Covid-19

In fact, paracetamol is an analgesic drug that can relieve many painful manifestations, including symptoms of Covid-19, such as headaches, fever, dental or joint pain, flu-like conditions, painful periods, etc. It generally works about twenty minutes after taking it and for four hours.

For adults, the maximum generally recommended dose is one gram per dose, three times a day, at least six hours apart. In case of non-compliance with this dosage -unless otherwise indicated by a doctor-, the patient is exposed to risks because this drug can be toxic to the liver and have serious consequences, according to the Vidal.

do not store

Currently, to limit the risk of shortages and maintain control over quantities, the ANSM recommends that the French take this medicine in moderation, when really necessary and, above all, not to make a preventive stock.

At the same time, the ANSM has also reduced the quantities delivered to pharmacies, according to 20 minutes and recommended that pharmacists limit orders and regulate sales by favoring prescription dispensing.

No impact on the hospital

Mélanie Cachet, deputy director of the ANSM inspection department, told Agence France Presse (AFP) that these measures should allow “all patients can have access to the medicine“.

In the current state, this tension on paracetamol should not have an impact on the hospital: the ANSM specified that its supply was assured. The pharmaceutical group Sanofi, which produces this drug, told AFP that there was “no risk of paracetamol rupture in France”.

Leave a Comment